Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer

Minting Chen; Keying Zhong; Jincheng  Tan; Mingjing Meng Meng; Chok Mei  Liu; Baisen Chen; Chunhua Huang; Hoi Leong Xavier Wong; Zhaoxiang Bian; Tao Su; Hiu Yee Kwan

doi:10.1002/ctm2.564

Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer

Minting Chen, Keying Zhong, Jincheng Tan, Mingjing Meng Meng, Chok Mei Liu, Baisen Chen, Chunhua Huang, Hoi Leong Xavier Wong, Zhaoxiang Bian, Tao Su^*, Hiu Yee Kwan^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e564
Journal	Clinical and Translational Medicine
Volume	11
Issue number	11
DOIs	https://doi.org/10.1002/ctm2.564
Publication status	Published - Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ctm2.564

Cite this

@article{5d5e64cc77d4468281cb69d4005addbf,

title = "Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer",

author = "Minting Chen and Keying Zhong and Jincheng Tan and Meng, {Mingjing Meng} and Liu, {Chok Mei} and Baisen Chen and Chunhua Huang and Wong, {Hoi Leong Xavier} and Zhaoxiang Bian and Tao Su and Kwan, {Hiu Yee}",

year = "2021",

month = nov,

doi = "10.1002/ctm2.564",

language = "English",

volume = "11",

journal = "Clinical and Translational Medicine",

issn = "2001-1326",

publisher = "Wiley",

number = "11",

}

TY - JOUR

T1 - Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer

AU - Chen, Minting

AU - Zhong, Keying

AU - Tan, Jincheng

AU - Meng, Mingjing Meng

AU - Liu, Chok Mei

AU - Chen, Baisen

AU - Huang, Chunhua

AU - Wong, Hoi Leong Xavier

AU - Bian, Zhaoxiang

AU - Su, Tao

AU - Kwan, Hiu Yee

PY - 2021/11

Y1 - 2021/11

U2 - 10.1002/ctm2.564

DO - 10.1002/ctm2.564

M3 - Letter

SN - 2001-1326

VL - 11

JO - Clinical and Translational Medicine

JF - Clinical and Translational Medicine

IS - 11

M1 - e564

ER -